Geistlich Pharma AG
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
3
Ending by 2030
Dec 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 28, 2026The maintenance fee for Resorbable crosslinked form stable membrane (US 10,300,171) comes due Nov 28, 2026. Unpaid by May 28, 2027, it lapses early.
- 1 fee due Dec 30, 2026The maintenance fee for Bone substitute material (US 9,066,995) comes due Dec 30, 2026. Unpaid by Jun 30, 2027, it lapses early.
- 1 fee due Nov 12, 2027The maintenance fee for Bone substitute material (US 10,646,615) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 21, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,084,428 | Method of repairing meniscal tears In force · USPTO record | In force | USPTO record | |
| US D721,803 | Syringe In force · USPTO record | In force | USPTO record | |
| US 8,992,946 | Method and Membrane for Tissue Regeneration In force · High confidence | In force | High confidence | |
| US 8,491,592 | Device for the application of bone substitute material In force · USPTO record | In force | USPTO record | |
| US 9,066,995 | Bone substitute material In force · USPTO record | In force | USPTO record | |
| US D812,762 | Collagen membrane In force · USPTO record | In force | USPTO record | |
| US RE48,536 | Collagen sponge In force · USPTO record | In force | USPTO record | |
| US 12,534,443 | Processes for Preparing Oxathiazin-Like Compounds In force · High confidence | In force | High confidence | |
| US 10,300,171 | Resorbable crosslinked form stable membrane In force · USPTO record | In force | USPTO record | |
| US 10,646,615 | Bone substitute material In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 19: 10 patents in force now held by others · 9 lapsed for an unpaid fee · 9 ended at full term · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 3 no status recorded
Showing 1 to 4 of 4, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 17/612,953 | May 21, 2020 | No status recorded | |
| 17/612,950 | Oxathiazin Compounds for Inhibiting Gapdh | May 21, 2020 | Abandoned |
| 14/415,870 | Jul 29, 2013 | No status recorded | |
| 12/334,145 | Dec 12, 2008 | No status recorded |